Sexual Dysfunction

“Always look at the patient as…a whole and not only [their] testosterone levels,” says Karim Sultan Haider, MD.

In a recent study presented at the 2021 SMSNA Fall Scientific Meeting, Jay Newmark, MD, MBA, and co-authors report promising findings on the first experiences of patients using JATENZO in the real world.

"We should think about a man’s mentality and recognize the impact on his overall physical, mental, emotional health. Sexual function is part of all that wellness, so I would certainly underscore that message we're talking about today," said Arthur L. Burnett, MD, MBA, FACS.

“The data…showed us that a lot of young [men]…are coming in for ED, and we can't really think of it as just a disease of older men…It can affect you at any age,” says Denise Asafu-Adjei, MD, MPH.

“The majority of treatments out there don't allow the maintenance of ejaculation after surgery, whereas here, we're at 90% for the small glands…[and at] 81% [for] the men who had prostates above 80 grams,” says Naeem Bhojani, MD, FRCSC.

Madeline Zech Ruiz discusses why she included chapters on premature ejaculation and genitourinary symptoms of menopause in her book “I Married a Urologist.”

According to recently published studies, having COVID-19 could have lasting impacts on fertility and sexual function.

Receiving Nesbit’s surgical procedure for Peyronie’s disease does not result in deterioration of erectile function.

“We found that medications allegedly causing priapism and the litigation surrounding that is significant because it means that the patient-physician relationship was not well established,” says Ariana Matz, MD.

No serious complications occurred during or following the surgical procedure.

There were no reductions in any sperm parameters, including semen volume, sperm concentration, sperm motility, and total motile sperm count.

In this interview, Parviz K. Kavoussi, MD, discusses his diagnostic work-up for patients who present with chronic testicular pain and describes conservative and surgical management approaches for the condition.

“I think doctors should be aware that if men do complain of erectile dysfunction after [having] COVID-19 that it could be because of underlying endothelial dysfunction and underlying vasculature issues,” Ramasamy says.

Depression appears to be common in patients, retrospective data indicate.

Men with Peyronie’s disease have an increased risk of being diagnosed with a substance use disorder, anxiety disorder, depression, and self-injurious behaviors.

O’Leary discusses safety related to instillation of the Penuma penile enhancement implant.

Compared with single men, those in this age group who were married/partnered had 65% lower odds of having ED.

Victoria S. Edmonds and Tobias Köhler, MD, MPH, discuss trends in reimbursement for men's health procedures from 2002 to 2020.

Experts in prostate cancer, bladder cancer, kidney stones, OAB/incontinence, BPH, and sexual dysfunction recap all the key advances from 2020.

The findings support continued investigation of the safety and efficacy of mirabegron in men with OAB and concurrent ED, says study author Arthur L. Burnett, II, MD, MBA.

Men using the RestoreX traction device saw a median 1.6-cm increase in length at 6 months, versus a median of 0.3 to 0.7 cm for controls.

Christopher Warren discusses steps urologists can take to create and/or share patient education videos regarding Peyronie disease.

Men who receive care for erectile dysfunction from their primary care provider are much less likely to receive advanced pharmacological therapies for management of their condition than those treated by urologists.

Ranjith Ramasamy, MD, discusses a recent study evaluating the testosterone nasal gel Natesto.

"While we generally don’t perform surgery for PD in the first year, it makes sense to treat these patients earlier with intralesional collagenase clostridium histolyticum," says Wayne J.G. Hellstrom, MD.

Retreatment rates were low with both aquablation and transurethral resection of the prostate.

In patients with prior exposure to PDE5 inhibitors, increasing the number of sessions of low-intensity shockwave therapy was associated with improving outcomes.

Trinity Bivalacqua, MD, PhD, discusses the available evidence for the use of restorative therapies for erectile dysfunction.

The AUA 2018 sexual dysfunction take-home messages also included a novel end-to-side nerve grafting procedure for men with post-radical-prostatectomy ED as well as the finding that use of a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor does not appear to change the adverse effect profile of flibanserin (Addyi).

To help you sift the enormous scientific program and prioritize your schedule at the AUA annual meeting, the editors have called upon Urology Times’ editorial advisory board to identify the key research across multiple areas of the specialty.